Axsome Therapeutics Stock (NASDAQ: AXSM)
|Day Range45.56 - 47.57||52 Wk Range20.63 - 71.98||Open / Close46.1 / 46.96||Float / Outstanding34.9M / 42.9M|
|Vol / Avg.835.2K / 1.5M||Mkt Cap2B||P/E-||50d Avg. Price51.95|
|Div / Yield-||Payout Ratio-||Total Float34.9M||EPS-1.06|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Axsome Therapeutics (NASDAQ: AXSM) through any online brokerage.
The latest price target for Axsome Therapeutics (NASDAQ: AXSM) was reported by Jefferies on Friday, September 30, 2022. The analyst firm set a price target for 90.00 expecting AXSM to rise to within 12 months (a possible 91.65% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $46.96 last updated Today at October 4, 2022, 8:00 PM UTC.
There are no upcoming dividends for Axsome Therapeutics.
Axsome Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Axsome Therapeutics.
Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.